A b s t r a c tMycobacterioses are a constant problem in backyard poultry, as well as pet birds. To date, no evidence of direct transmission of atypical bacilli between humans has been demonstrated, but it cannot be ruled out that sick animals can be a source of infection for people in their environment. The aim of the study was to identify mycobacteria isolated from birds with diagnosed mycobacteriosis and to determine the susceptibility of mycobacterial isolates from these animals to antituberculous drugs most commonly used in the treatment of mycobacterial infections in humans. For drug susceptibility tests, drugs such as isoniazid, rifampicin, streptomycin, ethambutol, ofloxacin, capreomycin, cycloserine and ethionamide were used. A high degree of drug resistance was demonstrated, particularly in Mycobacterium avium. Isolates of Mycobacterium xenopi showed a relatively good susceptibility to the drugs tested. The drug resistance of Mycobacterium genavense has not been determined, but this mycobacterium was identified in ten cases, which is the second most frequent occurrence in the cases studied. K e y w o r d s: avian mycobacteriosis, mycobacteriosis, Mycobacterium avium, Mycobacterium xenopi, Mycobacterium genavense, drug susceptibility tests Conflict of interest Author does not report any financial or personal connections with other persons or organizations, which might negatively affect the contents of this publication and/or claim authorship rights to this publication. Literature Adzic-Vukicevic T, Barac A., Blanka-Protic A., Laban-Lazovic M., Lukovic B., Skodric-Trifunovic V. and Rubino S. 2018. Clinical features of infection caused by non-tuberculous mycobacteria: 7 years' experience. Infection. 46:357-363. Augustynowicz-Kopeć E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M. 2003. Drug-resistant tuberculosis in Poland in 2000: second national survey and comparison with the 1997 survey. Int J Tuberc Lung Dis. 7(7):645-651. Bluth MH, Vera R, Razeq J, Kramer M, Abu-Lawi KI. 2009. Mycobacterium xenopi: evidence for increased rate of clinical isolation. Int J Biomed Sci. 5(2):96-100. Chevrier D, Oprisan G, Maresca A, Matsiota-Bernard P, Guesdon JL. 1999. Isolation of a specific DNA fragment and development of a PCR-based method for the detection of Mycobacterium genavense. FEMS Immunol Med Microbiol. 23(3):243-252. Coyle MB, Carlson LC, Wallis CK, Leonard RB, Raisys VA, Kilburn JO, Samadpour M, Böttger EC. 1992. Laboratory aspects of "Mycobacterium genavense" a species isolated from AIDS patients. J Clin Microbiol. 30(12):3206-3212. de Lastours V, Guillemain R, Mainardi JL, Aubert A, Chevalier P, Lefort A, Podglajen I. 2008. Early diagnosis of disseminated Mycobacterium genavense infection. Emerg Infect Dis. 14(2): 346-347.